Unraveling the potential: mRNA therapeutics in oncology
Messenger ribonucleic acid (mRNA) technology is a promising platform for cancer immunotherapy. Unlike traditional vaccines that prevent infectious diseases, mRNA’s role in oncology is to stimulate or enhance the immune response against tumor antigens. This review provides an overview of mRNA’s histo...
Saved in:
| Main Authors: | Karol Gawalski, Weronika Przybyszewska, Jaromir Hunia, Alicja Gawalska, Aleksandra Rymarz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1643444/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities
by: Zhen Lv, et al.
Published: (2025-07-01) -
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
by: Jiawei Zeng, et al.
Published: (2023-12-01) -
Impact of PEGylation and hyaluronan functionalization on lipoplex-mediated mRNA delivery to the canine retina
by: Tatyana Appelbaum, et al.
Published: (2025-12-01) -
mRNA turnover rate limits siRNA and microRNA efficacy
by: Erik Larsson, et al.
Published: (2010-11-01) -
Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
by: Hector R. Mendez-Gomez, et al.
Published: (2025-12-01)